Aier Eye Hospital Group Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000GR6
CNY
10.55
0.01 (0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

67.82 M

Shareholding (Sep 2025)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Positive results in Sep 25

  • DIVIDEND PAYOUT RATIO(Y) Highest at 69.5%
  • RAW MATERIAL COST(Y) Fallen by -0.02% (YoY)
  • DEBTORS TURNOVER RATIO(HY) Highest at 9.48 times
2

With ROE of 16.83%, it has a expensive valuation with a 5.31 Price to Book Value

3

Majority shareholders : Non Institution

 
4

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CNY 82,179 Million (Large Cap)

stock-summary
P/E

32.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.59%

stock-summary
Debt Equity

-0.19

stock-summary
Return on Equity

15.09%

stock-summary
Price to Book

3.66

Revenue and Profits:
Net Sales:
6,396 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,315 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.7%
0%
-4.7%
6 Months
-12.52%
0%
-12.52%
1 Year
-19.22%
0%
-19.22%
2 Years
-18.28%
0%
-18.28%
3 Years
-63.63%
0%
-63.63%
4 Years
-70.84%
0%
-70.84%
5 Years
-84.77%
0%
-84.77%

Aier Eye Hospital Group Co., Ltd. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.44%
EBIT Growth (5y)
12.22%
EBIT to Interest (avg)
25.06
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.22
Sales to Capital Employed (avg)
0.92
Tax Ratio
18.05%
Dividend Payout Ratio
41.71%
Pledged Shares
0
Institutional Holding
0.00%
ROCE (avg)
36.77%
ROE (avg)
21.32%

Valuation key factors

Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
5.31
EV to EBIT
24.86
EV to EBITDA
16.82
EV to Capital Employed
6.01
EV to Sales
5.11
PEG Ratio
NA
Dividend Yield
1.30%
ROCE (Latest)
24.18%
ROE (Latest)
16.83%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 6.15% vs 16.27% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 12.70% vs 19.96% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,396.50",
          "val2": "6,026.10",
          "chgp": "6.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,643.80",
          "val2": "2,039.00",
          "chgp": "-19.38%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "63.20",
          "val2": "69.50",
          "chgp": "-9.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.00",
          "val2": "3.30",
          "chgp": "-251.52%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,314.70",
          "val2": "1,166.50",
          "chgp": "12.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "257.00%",
          "val2": "242.40%",
          "chgp": "1.46%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 6.55% vs 3.03% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -7.04% vs 2.19% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "22,321.30",
          "val2": "20,948.80",
          "chgp": "6.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "6,907.10",
          "val2": "6,403.10",
          "chgp": "7.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "319.50",
          "val2": "300.00",
          "chgp": "6.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-62.70",
          "val2": "146.60",
          "chgp": "-142.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3,473.20",
          "val2": "3,736.10",
          "chgp": "-7.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "209.30%",
          "val2": "212.70%",
          "chgp": "-0.34%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoYstock-summary

Mar'26
Mar'25
Change(%)
Net Sales
6,396.50
6,026.10
6.15%
Operating Profit (PBDIT) excl Other Income
1,643.80
2,039.00
-19.38%
Interest
63.20
69.50
-9.06%
Exceptional Items
-5.00
3.30
-251.52%
Consolidate Net Profit
1,314.70
1,166.50
12.70%
Operating Profit Margin (Excl OI)
257.00%
242.40%
1.46%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Mar 2026 is 6.15% vs 16.27% in Mar 2025

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 12.70% vs 19.96% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
22,321.30
20,948.80
6.55%
Operating Profit (PBDIT) excl Other Income
6,907.10
6,403.10
7.87%
Interest
319.50
300.00
6.50%
Exceptional Items
-62.70
146.60
-142.77%
Consolidate Net Profit
3,473.20
3,736.10
-7.04%
Operating Profit Margin (Excl OI)
209.30%
212.70%
-0.34%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 6.55% vs 3.03% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -7.04% vs 2.19% in Dec 2024

stock-summaryCompany CV
About Aier Eye Hospital Group Co., Ltd. stock-summary
stock-summary
Aier Eye Hospital Group Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available